Question 1

Purpose of the Procedure

Accepted Answer

Determine if the fetus is Rh-positive or Rh-negative. Avoid unnecessary Anti-D injections if the fetus is Rh-negative. Prevent Rhesus disease and related pregnancy complications.

Question 2

Target Groups

Accepted Answer

Pregnant women with Rh-negative blood type. Expectant mothers seeking to minimize unnecessary immunotherapy. Management of pregnancies at risk of blood group incompatibility.

Question 3

Benefits of Non-Invasive Testing

Accepted Answer

Zero risk of miscarriage compared to invasive methods. High accuracy rates exceeding 99%. Early detection from the 11th week of gestation.

Safe Fetal RhD Blood Testing - Non-Invasive Fetal RhD Genotyping